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Abstract. 
 
ATP hydrolysis has been regarded as a gen-
eral requirement for internalization processes in mam-
malian cells. We found, however, that treatment of 
ATP-depleted macrophages and fibroblasts with exog-
enous sphingomyelinase (SMase) rapidly induces for-
mation of numerous vesicles that pinch off from the 
plasma membrane; the process is complete within 10 
min after adding SMase. By electron microscopy, the 
 
SMase-induced vesicles are 
 
z
 
400 nm in diameter and 
lack discernible coats. 15–30% of plasma membrane is 
internalized by SMase treatment, and there is no de-
tectable enrichment of either clathrin or caveolin in 
these vesicles. When ATP is restored to the cells, the 
SMase-induced vesicles are able to deliver fluid-phase 
markers to late endosomes/lysosomes and return recy-
cling receptors, such as transferrin receptors, back to 
the plasma membrane. We speculate that hydrolysis of 
sphingomyelin on the plasma membrane causes inward 
curvature and subsequent fusion to form sealed vesi-
cles. Many cell types express a SMase that can be se-
creted or delivered to endosomes and lysosomes. The 
hydrolysis of sphingomyelin by these enzymes is acti-
vated by several signaling pathways, and this may lead 
to formation of vesicles by the process described here.
 
M
 
ammalian 
 
cells use several mechanisms for in-
ternalizing fluids and membrane components.
These include receptor-mediated endocytosis
via clathrin-coated pits, actin-based phagocytosis, and the
pinching off of various types of uncoated membranes (Muk-
herjee et al., 1997). ATP use has been considered to be a
hallmark of all internalization processes (Silverstein et al.,
1977). The mechanisms for budding and pinching off of
endocytic vesicles from the plasma membrane are only
partially understood. It has been shown that there are at
least two ATP-dependent steps in the formation of clathrin-
coated vesicles (Schmid and Smythe, 1991). One of these
steps apparently involves the invagination of the membrane,
and the second is the complete sealing of the vesicle, a pro-
cess that requires fusion of the plasma membrane with it-
self. The general mechanism by which ATP catalyzes bud-
ding and fusion is not known at present.
The role of lipid components in vesicle budding and fu-
sion in living cells is poorly understood. Recent studies
have shown that phosphatidylinositol (PI)3
 
1
 
 kinase is in-
volved in several steps of vesicle traffic in mammalian cells
(Shepherd et al., 1996). Inhibition of PI3 kinase by wort-
mannin and LY294002 was reported to prevent invagi-
nated phagosomes from closure on the plasma membrane
(Araki et al., 1996). The mechanisms by which PI3 kinase
activity modulates vesicle traffic are not known. Treat-
ment of Golgi membranes with bacterial phospholipase D
stimulates coatomer binding (Ktistakis et al., 1996), and
this may be part of a mechanism for controlling vesicle
budding in the Golgi (Bednarek et al., 1996). Through
studies in model membrane systems, it is known that bud-
ding can be facilitated by altering lipid composition to pro-
vide favorable membrane bending energy (Sackmann,
1994; Chernomordik et al., 1995). This favorable bending
energy can arise through enrichment of certain types of
lipids in an asymmetrical lipid bilayer. Alteration of lipid
composition can also create a local phase separation so
that fusion is facilitated after membrane bending. For in-
stance, membrane fusion in dimyristoylphosphatidylcho-
line–cholesterol vesicles was attributed to the accumula-
tion of cholesterol that formed a separate phase within the
neck interconnecting the membranes (Knoll et al., 1985).
In an investigation of the ATP dependence of choles-
terol esterification, we treated J774 macrophages with ex-
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1. 
 
Abbreviations used in this paper
 
: ACAT, acetyl-CoA-cholesterol acyl
transferase; BODIPY-C
 
12
 
-SM, 4,4-difluoro-4-bora-3a,4a-diaza-s-indacene-
C12-sphingomyelin; C6-NBD-gal, 
 
N
 
-([6-{7-nitrobenz-2-oxa-1,3-diazol-4-yl}
amino] hexanoyl) sphingosyl phosphocholine; PC, phosphatidyl choline;
SL-O, streptolysin O; SMase, sphingomyelinase; Tf, transferrin; TRITC,
tetramethylrhodamine isothiocyanate.
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ogenous sphingomyelinase (SMase), which was shown
previously to enhance delivery of plasma membrane cho-
lesterol to a microsomal enzyme, acetyl-CoA-cholesterol
acyl transferase (ACAT; Slotte et al., 1990). Since choles-
terol preferentially associates with sphingomyelin in mem-
branes (Gronberg et al., 1991), it was thought that deple-
tion of sphingomyelin by SMase treatment would cause
release of cholesterol from the plasma membrane, allow-
ing its transport to ACAT. We found that enhanced cho-
lesterol delivery because of SMase was not affected by
ATP depletion but was associated with the formation of
membrane vesicles (Skiba et al., 1996). We report here that
treatment of cells with SMase rapidly induces formation of
numerous vesicles that pinch off from the plasma mem-
brane, and the formation of these endocytic compartments
does not require cellular ATP. Electron microscopic visu-
alization shows that the sphingomyelinase-induced vesi-
cles are 
 
z
 
400 nm in diameter and lack discernible coats.
 
Materials and Methods
 
Materials
 
SMase (
 
Bacillus cereus
 
), sodium azide, 2-deoxyglucose, Lucifer yellow,
and ATP bioluminescent assay kit were purchased (Sigma Chemical Co.,
St. Louis, MO). FITC-dextran (70-kD), tetramethylrhodamine isothiocy-
anate (TRITC)-dextran (70-kD), rhodamine-dextran (70-kD), and 4,4-dif-
luoro-4-bora-3a,4a-diaza-s-indacene-c12-sphingomyelin (BODIPY-C
 
12
 
-SM)
were from Molecular Probes (Eugene, OR). SMase (
 
Staphylococcus au-
reus
 
) was from ICN Biomedicals Inc. (Irvine, CA). Streptolysin O (SL-O)
was obtained from Murex Diagnostics (Atlanta, GA). Human transferrin
(Tf; Sigma Chemical Co.) was iron-loaded, purified by Sephacryl S-300
(Pharmacia Diagnostics AB, Uppsala, Sweden), and labeled with fluoro-
phore Cy3 (Biological Detection Systems, Pittsburgh, PA) according to
the manufacturer’s instructions. Rabbit polyclonal antibody to caveolin/
VIP-2 was purchased from Transduction Laboratories (Lexington, KY),
and mouse monoclonal antibodies against adaptor protein 2 (AP6) and
clathrin (X22) were gifts from F. Brodsky (University of California, San
Francisco, CA).
 
Cells
 
J774 cells (American Type Culture Collection, Rockville, MD) were
maintained in spinner culture in DME (Gibco Laboratories, Grand Is-
land, NY) with 10% FCS. TRVb-1 cells (McGraw et al., 1987), a CHO cell
line lacking endogenous transferrin receptor and expressing transfected
human Tf receptors, were cultured in HF-12 (Gibco Laboratories) with
5% FCS. 2 d before an experiment, cells were plated on polylysine-coated
coverslip-bottom dishes (Salzman and Maxfield, 1988). All experiments
were performed on day 3 unless otherwise mentioned. ATP measure-
ments were performed on both J774 macrophages and TRVb-1 cells using
an ATP bioluminescent assay kit (Sigma Chemical Co.). Cells grown on
12-well culture dishes were pretreated with sodium azide/2-deoxyglucose
for 5 min to deplete ATP and then incubated with or without SMase for
an additional 10 min at 37
 
8
 
C before ATP assay. To measure ATP in per-
meabilized cells, cells were preincubated with sodium azide/2-deoxyglu-
cose for 5 min and cooled to 0
 
8
 
C. Cells were then treated with SL-O (0.4
U/ml) for 5 min on ice, rinsed three times with cold PBS, and transferred
to 37
 
8
 
C for 10 min. After a 10-min incubation with SMase, cells were
washed and assayed for ATP.
 
Fluorescence Microscopy
 
In most experiments, cells were preincubated for 5 min in medium alone
or containing 2-deoxyglucose and sodium azide. The cells were then incu-
bated in the same medium containing 5 mg/ml FITC-dextran alone, or
plus 50 mU/ml SMase for 10 min before being fixed with 4% paraformal-
dehyde for 5 min in PBS. Cells were immediately viewed using a micro-
scope (model Diavert; Leitz, Wetzlar, Germany) with a 63
 
3
 
, NA 1.4 ob-
jective, and recorded with a cooled charge-coupled device (CCD) camera
(KAF 1400; Photometrics, Tucson, AZ). To quantify the endocytosed
FITC-dextran, fluorescence images of cells were taken using the same sys-
tem as above but with a 25
 
3
 
, NA 0.8 objective. Total fluorescence inten-
sity from a field of cells (
 
z
 
70 cells) was measured and, after background
correction, divided by the number of cells in the field. Each data point
represents an average of four or five fields. For immunofluorescence ex-
periments, cells were fixed with 4% paraformaldehyde in PBS for 10 min
and then permeabilized with 0.1 mg/ml saponin before incubating with
primary antibodies and a TRITC-conjugated secondary antibody. Confo-
cal fluorescence images were obtained with a laser scanning confocal mi-
croscope (model MRC600; Bio-Rad Microscience, Cambridge, MA).
FITC-dextran and Cy3-Tf images in Fig. 8 were obtained using an image-
intensified video camera (model K51380; Videoscope, Washington, DC)
on a fluorescence microscope (model DMIRB; Leica Inc., St. Gallen,
Switzerland) using a 63
 
3
 
, NA 1.32 objective.
 
Electron Microscopy
 
After incubating with HRP plus SMase for 10 min, ATP-depleted cells
were fixed with 3.5% glutaraldehyde in 100 mM Hepes, pH 7.4, for 15 min
at 22
 
8
 
C. After three rinses of 5 min each with TBS (50 mM Tris, pH 7.4,
100 mM NaCl), cells were incubated with 10 mg/ml diaminobenzidine in
TBS with 0.3% H
 
2
 
O
 
2
 
 for 60 min at room temperature with agitation. Cells
were rinsed with three washes of 100 mM sodium cacodylate, pH 6.8, and
then postfixed with 1% osmium tetroxide and 1.25% potassium ferrocya-
nide in 100 mM sodium cacodylate for 4 h at room temperature. After two
rinses with 100 mM sodium cacodylate, cells were dehydrated in a graded
series of ethanol, embedded in Epon, and sectioned in the plane of the
monolayer. Thin sections (80 nm) were counterstained with uranyl acetate
and lead citrate before observation using a transmission electron micro-
scope (model 1200EX II; JEOL USA, Peabody, MA) operating at 80 kV.
 
Quantification of Endocytosed Plasma Membrane
 
N
 
-([6-{7-nitrobenz-2-oxa-1,3-diazol-4-yl} amino] hexanoyl) sphingosyl phos-
phocholine (C
 
6
 
-NBD-gal) was prepared as described previously (Mayor et al.,
1993). C
 
6
 
-NBD-gal/lipid vesicles (100 
 
m
 
M total lipid) were prepared by
injecting an ethanolic solution of a 1:1 mixture of C
 
6
 
-NBD-gal and dioleyl-
phosphatidylcholine (DOPC; 2:5 mM total lipid; Avanti Polar Lipids, Inc.,
Albaster, AL) into 150 mM NaCl, 20 mM Hepes, pH 7.4. TRVb-1 cells
were incubated on ice with 3 
 
m
 
M of this vesicle solution (
 
,
 
0.2% ethanol)
in Hepes-buffered, glucose-free Hams HF-12 medium (HF-12; Specialty
Media, Inc., Lavallette, NJ) for 30 min. Cells were washed extensively with
ice-cold HF-12, incubated with 5 mM 2-deoxyglucose and 5 mM sodium
azide for 10 min at 37
 
8
 
C, and then incubated for an additional 10 min at
37
 
8
 
C in the same medium with or without 50 mU/ml SMase. For some
samples, the lipid label remaining on the plasma membrane was backex-
changed by washing (in six rinses of 5 min each) with ice-cold HF-12
containing 5% BSA. All samples were washed with cold PBS before lysis
with 1% Triton X-100, and then C
 
6
 
-NBD-gal was extracted from the sam-
ples by homogenizing the lysates with chloroform. The C
 
6
 
-NBD-gal con-
tent in the chloroform extracts was determined with an SLM 8000C spec-
trofluorometer (Aminco, Urbana, IL).
Cells were prepared for microscopy as above except that cells were la-
beled with 0.75 
 
m
 
M C
 
6
 
-NBD-gal. Cells were fixed with 3.3% paraformal-
dehyde after the backexchange step, and images were acquired with a
cooled CCD camera (model 30427; Princeton Instruments, Princeton, NJ)
on a fluorescence microscope (model DMIRB; Leica, Inc.). Because con-
centration-dependent self-quenching of C
 
6
 
-NBD-gal could lead to under-
estimation of total fluorescence, NBD fluorescence emission was inte-
grated over time until photobleaching was complete. This method allows
the accurate quantification of total fluorescence (Jovin and Arndt-Jovin,
1989).
 
SMase Treatment of
BODIPY-C
 
12
 
-sphingomyelin–labeled,
SL-O–permeabilized Cells
 
43 
 
m
 
g of BODIPY-C
 
12
 
- SM (1 mg/ml in DMSO) was mixed with 20 
 
m
 
l of
5 mM DOPC in ethanol. The mixture was evaporated for 30 min under ar-
gon to remove ethanol and then centrifuged for 20 min at 4
 
8
 
C and 100,000 
 
g.
 
The supernatant was then rapidly injected into 1.5 ml PBS to yield a BO-
DIPY-C
 
12
 
-SM stock solution. To label the plasma membrane, TRVb-1
cells were chilled to 0
 
8
 
C for about 20 min and were then incubated with
BODIPY-C
 
12
 
-SM (1:5 dilution of stock solution with HF-12 medium) for 
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30 min at 0
 
8
 
C. Cells were washed with cold PBS three times to remove un-
bound BODIPY-C
 
12
 
-SM. Some of the cells were further incubated with
SL-O (0.4 U/ml) for 5 min at 0
 
8
 
C and then washed with cold PBS three
times. Cells were then transferred to 37
 
8
 
C for 3 min, treated with SMase
(50 mU/ml)/rhodamine-dextran for 5 min, washed with medium 1 and then
immediately observed by fluorescence microscopy.
 
Results
 
SMase-induced, ATP-independent Vesicle Formation in 
J774 Macrophages
 
Fig. 1 
 
a
 
 shows the uptake of a fluid endocytosis marker,
FITC-dextran, by J774 cells during a 10-min incubation at
37
 
8
 
C. These control cells internalize FITC-dextran and de-
liver it to endosomes that are seen as bright fluorescent
dots. As expected, this uptake is blocked when cellular
ATP is depleted by preincubation with sodium azide and
2-deoxyglucose (Fig. 1 
 
b
 
). Under the conditions used for
Fig. 1 
 
b
 
, cellular ATP is 2.4 
 
6
 
 0.5% of control values, as
determined by an ATP luminescence assay. When ATP-
depleted cells are treated with SMase (50 mU/ml), there is
substantial uptake of FITC-dextran into the cells (Fig. 1 
 
c
 
).
SMase treatment had no effect on cellular ATP levels. To
determine whether FITC-dextran is in sealed vesicles,
these cells were either chased in dextran-free medium for
long periods of time, or exposed to trypan blue, a mem-
brane-impermeant quencher of FITC fluorescence (Hed
et al., 1987). FITC-dextran labeling was not reduced after
a 60-min chase, and the fluorescence was not quenched by
2 mg/ml trypan blue (data not shown). It has been shown
previously that trypan blue is able to quench fluorescence
even in deep surface invaginations (Myers et al., 1993),
and the lack of quenching is strong evidence for the seal-
ing of the SMase-induced vesicles. As seen in Fig. 1 
 
c
 
,
these vesicles remain in the cell periphery, consistent with
the requirement for ATP-dependent motor proteins such
as dynein for translocation of vesicles along microtubules
into the center of a cell (Holzbaur and Vallee, 1994).
When ATP is restored to the cells, these vesicles move
rapidly into the center (see below).
To visualize the SMase-induced vesicles by electron mi-
croscopy, ATP-depleted J774 cells were incubated for 10
min with HRP and 50 mU/ml SMase. Internalized HRP is
visualized after diaminobenzidine treatment as a dark pre-
cipitate. As shown in Fig. 2, SMase treatment induces the
formation of numerous vesicles that are typically 50–500
nm in diameter and marked by diaminobenzidine reaction
product precipitate along the lumenal face of the vesicle
Figure 1. Fluorescence mi-
croscopy of FITC-dextran
endocytosis in J774 macro-
phages. J774 macrophages
were preincubated for 5 min
in 0.2% BSA/DME alone
(a), or containing 100 mM
2-deoxyglucose and 100 mM
sodium azide (b and c). The
cells were then incubated in
the same medium containing
5 mg/ml FITC-dextran alone
(a and b), or plus 50 mU/ml
SMase (c) for 10 min. Cells
were fixed and examined by
fluorescence microscopy as
described in Materials and
Methods. Bar, 10 mm.
Figure 2. Electron microscopy of HRP endocytosis. J774 mac-
rophages were preincubated with sodium azide/2-deoxyglucose
(100 mM) for 5 min and then incubated in the same medium plus
SMase (50 mU/ml) and HRP (10 mg/ml) for 10 min. The cells
were fixed, incubated with diaminobenzidine and H2O2, and pro-
cessed for electron microscopy as described in Materials and
Methods. HRP-containing vesicles typically exhibited precipi-
tated diaminobenzidine along the lumenal edge of the compart-
ment (filled arrowheads). Lumenal diaminobenzidine precipita-
tion often formed a horseshoe shape (open arrowheads). A lack
of precipitated diaminobenzidine in the center of the compart-
ment indicated a relatively low concentration of soluble protein.
The SMase-induced compartments exhibited diameters ranging
from 50 to 500 nm. In the presence of energy poisons, SMase-
generated compartments exhibited a peripheral distribution in
the cytoplasm. Limiting membranes of SMase-generated com-
partments did not contain discernible coat structures and were not
continuous with membranes of any other organelles. Bar, 1 mm. 
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membranes. There was not a significant difference in ei-
ther the size distribution or number of vesicles when the
incubation time was reduced from 10 to 2.5 min (data not
shown). This suggests that the formation of vesicles is com-
plete in a few min after exposure to SMase. The SMase-
induced vesicles exhibit only peripheral staining, and no
internal vesicles are seen. We did not observe a discernible
coat on the vesicles.
 
SMase-induced Vesicle Formation in Fibroblasts
 
The formation of vesicles in response to SMase is also ob-
served in the TRVb-1 line derived from CHO fibroblasts.
An advantage to using CHO cells is that they are less ac-
tive in fluid uptake compared with macrophages, so the
effect of SMase can be examined even in the absence of
energy poisons. During a short incubation with FITC-dex-
tran (2.5 min) little uptake is observed in control cells (Fig.
3 
 
a
 
). When SMase is added to these energy-replete cells,
there is a burst of vesicle formation (Fig. 3 
 
b
 
), similar to
the vesicles induced by SMase treatment of ATP-depleted
cells (Fig. 3, 
 
c
 
 and 
 
d
 
). Therefore, SMase-induced vesicle
formation does not require ATP depletion, although we
have shown that SMase-induced vesicle formation is an
ATP-independent event. SMase-induced vesicles in en-
ergy-replete TRVb-1 cells (Fig. 3 
 
b
 
) were observed in the
cell periphery because of the short incubation (2.5 min);
vesicle formation because of SMase is completed within 5
min (earliest time point examined). Electron microscopy
using HRP showed that the SMase-induced vesicles in
TRVb-1 cells were structurally similar to those in J774
cells (data not shown).
To further verify that SMase-induced vesicle formation is
indeed ATP independent, TRVb-1 cells were incubated with
sodium azide/2-deoxyglucose and then permeabilized with
SL-O before being exposed to SMase. Cellular ATP level
in these cells after SMase treatment was down to 0.07 
 
6
 
0.01% of the level in intact, untreated cells. In response to
SMase treatment, the SL-O–permeabilized cells took up a
fluid-phase marker, Lucifer yellow in this experiment, into
peripheral vesicles (Fig. 4 
 
a
 
). SL-O permeabilization of
ATP-depleted cells without SMase did not induce vesicle
formation (data not shown). SMase-treated cells were able
to retain Lucifer yellow (mol wt 457) after a 2-h chase in a
dye-free medium (Fig. 4 
 
b
 
), indicating these vesicles are
completely sealed off from the plasma membrane.
To verify that the observed effects of SMase were be-
cause of SMase enzyme activity, we tested another SMase
from a different bacterial source. SMase from 
 
Staphylo-
coccus aureus
 
 had the same effect on TRVb-1 cells and
J774 cells as the SMase from 
 
Bacillus cereus.
 
 Furthermore,
when the SMase preparation was size-fractionated by fast
protein liquid chromatography, the vesicle-forming activ-
ity copurified with the SMase activity (data not shown).
 
Kinetics of SMase-induced Vesicle Formation
 
To determine the kinetics of SMase-induced vesicle for-
mation, J774 macrophages were incubated with FITC-dex-
tran with or without SMase for different lengths of time,
and total dextran uptake per cell was measured by quanti-
tative fluorescence microscopy. Results are shown in Fig.
5. As expected, in energy-replete cells treated with or
without SMase (
 
inset
 
), the uptake of dextran increased ap-
proximately linearly with time. ATP depletion completely
blocked dextran internalization in control cells (
 
closed
squares
 
), but SMase treatment of ATP-depleted cells
caused a rapid burst of dextran uptake (
 
closed circles
 
) that
is complete within 10 min (earliest time point examined).
Cells apparently became insensitive to SMase after the ini-
tial burst since longer exposure (
 
.
 
10 min) to SMase did
not result in additional internalization. FITC-dextran up-
Figure 3. Fluorescence microscopy of FITC-dextran uptake in
TRVb-1 cells. Cells were preincubated for 5 min in 0.2% BSA/
HF-12 medium (a and b), or glucose-free 0.2% BSA/HF-12 plus
5 mM 2-deoxyglucose and 5 mM sodium azide (c and d). The cells
were then incubated in the same medium with 5 mg/ml FITC-
dextran (a and c) or FITC-dextran plus SMase (50 mU/ml; b and
d) for 2.5 min. Cells were then fixed and viewed by fluorescence
microscopy. Bar, 10 mm.
Figure 4. Fluorescence microscopy of Lucifer yellow uptake and
retention in SL-O–permeabilized TRVb-1 cells. Cells were prein-
cubated for 10 min in 0.2% BSA/glucose-free HF-12 plus 10 mM
2-deoxyglucose and 10 mM sodium azide. The cells were then
chilled to 08C, treated with SL-O (0.4 U/ml) for 3 min, and fol-
lowed by three washes with cold PBS. After returning to 378C for
10 min, cells were exposed to Lucifer yellow (10 mg/ml) with
SMase (50 mU/ml) for another 10 min. The cells were either
viewed right away (a) or transferred into a medium free of Luci-
fer yellow for an additional 2 h before viewed by fluorescence mi-
croscopy (b). Bar, 10 mm. 
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take kinetics in TRVb-1 cells were similar to those of J774
cells (data not shown). The amount of FITC-dextran up-
take induced by SMase in TRVb-1 cells during a 5-min in-
cubation was equivalent to the fluid uptake by energy-
replete cells over a 20–30-min incubation.
 
Characterization of the Membrane Structures in 
SMase-induced Vesicles
 
To determine the extent of plasma membrane internaliza-
tion caused by SMase treatment, a fluorescent membrane-
lipid analogue, C
 
6
 
-NBD-gal, was used to label the plasma
membrane of TRVb-1 cells. Cells were incubated on ice
with C
 
6
 
-NBD-gal, depleted of ATP, and then treated with
or without SMase. As shown in Fig. 6, in the absence of
SMase the plasma membrane was relatively uniformly la-
beled by C
 
6
 
-NBD-gal (
 
a
 
), and a backexchange in BSA-con-
taining medium extracted most of this surface label (
 
b
 
).
SMase-treated cells (c) show more punctate labeling than
untreated cells. After surface C6-NBD-gal was removed by
backexchanging in BSA-containing medium, the periph-
eral punctate labeling of the SMase-treated cells is re-
tained (d). This retained C6-NBD-gal label resembles the
FITC-dextran uptake pattern in SMase-treated cells (Fig.
3 d). The fact that C6-NBD-gal in SMase-induced vesicles
is not available for backexchange provides further evi-
dence that these vesicles are completely sealed off from
the extracellular environment. After quantifying C6-NBD-
gal fluorescence images, we find that 30 6 5% (average of
five fields of cells 6 SD) of the plasma membrane C6-
NBD-gal is internalized in response to SMase. In parallel
experiments using a spectrofluorometer to detect C6-
NBD-gal extracted from solubilized cells, we find that 14 6
7% of the C6-NBD-gal label is resistant to backexchange
after treatment with SMase. The difference between the
results obtained by fluorometry and digital microscopy may
be explained by a small population of cells that take up a
large amount of C6-NBD-gal throughout the cell even on
ice (c). C6-NBD-gal in these cells can be extracted by back-
exchange. The fluorescence intensity of these cells, there-
fore, contributes to the total fluorescence intensity in the
spectrophotometric analysis but not the microscopic anal-
ysis, and this may account for the difference in the values
obtained from these two methods. Nevertheless, the re-
sults obtained by both methods show that the amount of
membrane internalized is much greater than the area cov-
ered by clathrin-coated pits and/or caveolae, which typi-
cally comprise only 2–4% of the plasma membrane. The
total intensities of the membrane C6-NBD-gal labeling of
ATP-depleted cells with or without SMase treatment are
not significantly different, indicating that SMase induces
endo- but not exovesiculation.
SMase-induced vesicles are formed from part of the
plasma membrane, raising the question as to whether they
are from some specialized or invaginated plasma mem-
brane regions. To address this, we examined if clathrin or
caveolae were preferentially associated with these vesicles.
TRVb-1 fibroblasts were treated with SMase in the pres-
ence of FITC-dextran, fixed, permeabilized, and stained
with antibodies against clathrin or adaptor protein 2 (AP2).
We did not find any significant enrichment of either clath-
Figure 5. Kinetics of dextran uptake in J774 macrophages. Cells
were preincubated for 5 min in 0.2% BSA/DME containing 100 mM
azide and 100 mM 2-deoxyglucose, or in the same medium with-
out energy poisons (inset). Cells were then incubated with 5 mg/ml
FITC-dextran (j, r) or FITC-dextran plus 50 mU/ml SMase (d,
.) for times <2 h. The uptake of FITC-dextran was then quanti-
fied by fluorescence microscopy as described previously (Dunn
and Maxfield, 1990). Each data point presents an average fluores-
cence intensity from four or five fields of cells (50–70 cells/fields)
6 SD. SMase treatment of energy-poisoned cells led to uptake of
FITC-dextran that was comparable to the cumulative uptake in
control cells after z20 min. In energy-replete cells (inset), SMase
treatment caused an increase in the initial dextran uptake with a
rate of sustained uptake similar to control cells.
Figure 6. SMase-induced endovesiculation of the plasma mem-
brane. The plasma membrane of TRVb-1 cells was labeled with the
fluorescent lipid analogue C6-NBD-gal. Cells were then energy
depleted by incubation with sodium azide/deoxyglucose (5 mM)
for 10 min at 378C. After a subsequent incubation in the same
medium with (c and d) or without (a and b) SMase (50 mU/ml),
the lipid label was backexchanged by washing with ice-cold me-
dium containing 5% BSA (b and d) or washed with ice-cold me-
dium alone (a and c). In the absence of SMase (a and b), almost
all of the C6-NBD-gal is backexchanged, whereas in the presence
of SMase, C6-NBD-gal located in peripheral vesicles is not avail-
able for backexchange. Bar, 10 mm.The Journal of Cell Biology, Volume 140, 1998 44
rin or AP2 in FITC-dextran–containing vesicles by immu-
nofluorescence microscopy (data not shown). When SMase-
treated cells were colabeled with antibody to caveolin/
VIP-21, the major protein in caveolae, there was no signif-
icant colocalization between caveolin and FITC-dextran
(data not shown). SMase-induced vesicles, therefore, ap-
pear to not be enriched in either clathrin-coated pits or ca-
veolae.
Sorting of Membrane and Fluid Content in
SMase-induced Vesicles
We next investigated the fate of internalized receptors and
the fluid contents of SMase-induced vesicles. J774 cells
were preincubated with TRITC-dextran to label the late
endosomes and lysosomes. The cells were then energy-
poisoned and incubated with SMase and FITC-dextran.
After 10 min, cells were rinsed and chased for an addi-
tional 60 min either in complete medium that allows resto-
ration of ATP, or in the continued presence of energy poi-
sons. In the continuous presence of energy poisons,
SMase-induced vesicles (FITC-dextran–containing vesi-
cles) remained in the cell periphery (Fig. 7 a), well sepa-
rated from the TRITC-dextran–labeled late endosomes
and lysosomes (Fig. 7 b). When ATP was restored, how-
ever, the FITC dextran in the SMase-induced vesicles
moved into the cell and merged with TRITC-dextran–con-
taining compartments (Fig. 7, c and d), indicating that
these vesicles are able to deliver FITC-dextran to the pre-
viously formed late endosomes and lysosomes.
To test if the SMase-induced vesicles are also able to
sort receptors for recycling, Cy3-transferrin was bound
onto the surface of ATP-depleted J774 cells. The cells
were then treated with SMase in the presence of FITC-
dextran. Transferrin that remained on the cell surface was
stripped off with a mild acid wash (Salzman and Maxfield,
1988). As shown in Fig. 8, Tf and dextran were initially in-
ternalized into the same compartments after SMase treat-
ment (Fig. 8, a and b). When the cells were returned to
complete medium in the absence of energy poisons, the Tf
(Fig. 8 d) was rapidly sorted away from the FITC-dextran
compartments (Fig. 8 c) and returned to the cell surface.
Thus, the contents of the SMase-induced vesicles can be
sorted with recycling receptors returned to the cell surface
and the remaining contents being delivered to late endo-
somes.
Ceramide Is Included in SMase-induced Vesicles
To understand the mechanism of SMase-induced vesicle
formation, it would be useful to know the lipid composi-
tion of these vesicles. As a start on these studies, we have
used a fluorescent sphingomyelin to determine if ceramide
formed from it enters the induced vesicles. We incor-
porated BODIPY-C12-SM into the plasma membrane of
TRVb-1 cells. When cells were exposed to SMase, a signif-
icant fraction of the BODIPY fluorescence translocated to
the Golgi region (Fig. 9 a). This is consistent with the be-
havior of fluorescent acyl chain derivatives of ceramide
that have been shown to be transported to the Golgi appa-
ratus by a nonvesicular mechanism (Martin and Pagano,
1994). The sphingomyelin analogue itself does not translo-
cate to the Golgi as demonstrated by the cells in Fig. 9 b,
which were incubated at 378C for the same time as the
cells in Fig. 9 a, but without SMase exposure. It is evident
that under our experimental conditions, SMase hydrolyzed
the majority of BODIPY-C12-SM and turned it into BO-
DIPY-C12-ceramide that could translocate to the Golgi.
Since the transport of fluorescent ceramides is thought to
occur via flipping to the cytoplasmic leaflet and binding to
cytoplasmic carrier proteins, it should be blocked by re-
moval of such proteins. This would allow us to observe the
presence of the ceramide in SMase-induced vesicles. We
permeabilized BODIPY-C12-SM–labeled cells with SL-O
to remove cytosol proteins. As shown in Fig. 9 d, SMase
treatment in these cells caused BODIPY fluorescence to
leave the plasma membrane and, significantly, to concen-
trate in SMase-induced vesicles that were labeled by
Figure 7. Fusion of SMase-induced vesicles with late endosomes/
lysosomes. J774 macrophages were incubated with TRITC-dext-
ran for 1 h and chased in dextran-free medium for 30 min. The
cells were then incubated for 5 min in 0.2% BSA/DME plus 100
mM 2-deoxyglucose/sodium azide, followed by a 10-min incuba-
tion in the same medium containing FITC-dextran (5 mg/ml) and
SMase (50 mU/ml). After rinsing, the cells were chased for 1 h ei-
ther in the same medium containing energy poisons (a and b) or
in complete medium without energy poisons (c and d). The cells
were fixed, and then a pair of fluorescence images of FITC-dext-
ran (a and c) and TRITC-dextran (b and d) were acquired from
each field of cells by confocal microscopy. In the continuous pres-
ence of energy poisons, the FITC-containing compartments re-
main in the periphery (a) and do not fuse with the TRITC-dextran–
labeled endosomes and lysosomes (b; arrows). In cells chased in
complete medium that allows restoration of ATP, there is exten-
sive colocalization between FITC-dextran–containing compart-
ments (c) and TRITC-dextran compartments (d; arrows). Bar,
10 mm.Zha et al. Sphingomyelin-induced Endocytosis 45
rhodamine-dextran (Fig 9 c). Taken together, these stud-
ies indicate that a substantial amount of the BODIPY ce-
ramide formed by SMase enters the induced vesicles, and
this BODIPY-C12-ceramide can flip to the cytoplasmic
leaflet.
Discussion
We have shown here that treatment of energy-depleted
macrophages and CHO cells with exogenous SMase in-
duces vesicle formation from the plasma membrane. To
our knowledge, this is the first instance of an internaliza-
tion process in living cells that does not require ATP.
SMase-induced vesiculation was reported in human eryth-
rocytes, although ATP dependence of the process was not
addressed (Allan and Walklin, 1988).
The mechanism by which SMase causes vesicle forma-
tion in our system is unclear. One possibility is that the
SMase causes an inward deformation of the lipid bilayer.
It is known that plasma membrane lipids are asymmetri-
cally distributed with sphingomyelin located mainly in the
outer leaflet of the bilayer (Koval and Pagano, 1991). Re-
moval of the head group from sphingomyelin would re-
duce crowding in the outer leaflet, and the ceramide pro-
duced by SMase could flip across the bilayer because of its
hydrophobicity (Pagano, 1990). Both of these processes
would promote inward curvature (Sheetz and Singer, 1974).
Ceramide may form droplets in the hydrophobic core of
the plasma membrane in human erythrocytes after SMase
treatment (Verkleij et al., 1973), and it can promote lipid
fusion in model systems (van Meer, 1993). Contact of cera-
mide-rich membranes at the neck of an invagination might
promote formation of sealed vesicles. Furthermore, it is
believed that sphingomyelin preferentially associates with
cholesterol, and removal of sphingomyelin from the plasma
membrane by SMase may result in the destabilization and
subsequent transport of cholesterol to intracellular loca-
tions (Slotte and Bierman, 1988). However, it is possible
that a substantial component of intracellular cholesterol
transport after SMase treatment may also occur by the ve-
sicular carriers described here (Skiba et al., 1996).
Ceramide can also function as a second messenger, trig-
gering a cascade of intracellular events (Obeid and Han-
nun, 1995). However, it is unlikely that the SMase-induced
vesicle formations in our system are related to the signal-
ing functions of ceramide. Ceramide was shown to inhibit
both fluid-phase and receptor-mediated endocytosis in a
dose-dependent manner (Chen et al., 1995). Interestingly,
in the same study SMase was also shown to inhibit endocy-
tosis. This is most likely because of experimental proce-
dures used in this study. The uptake of HRP as an endocy-
tosis marker was measured after a 20-min preincubation
with SMase. From our results, we know now that endocy-
tosis should actually be increased within the first 20 min in
Figure 8. Sorting of transferrin receptors in SMase-induced vesi-
cles. J774 macrophages were preincubated for 15 min in 0.2%
BSA/DME plus 100 mM 2-deoxyglucose/sodium azide, followed
by a 10-min incubation in the same medium containing Cy3-Tf
(20 mg/ml). Because of the energy depletion, Cy3-Tf was only
bound to the cell surface at this stage. The cells were then rinsed
and incubated in DME containing energy poisons, FITC-dextran,
and SMase for 10 min. At the end of this 10-min incubation, a
mild acid wash was performed to strip Cy3-Tf that still remained
on the cell surface. Cells were then either viewed immediately by
fluorescence microscopy (a and b) or chased in DME for 20 min
(c and d). Without any chase, internalized Cy3-Tf (b) was colo-
calized with FITC-dextran (a) in the peripheral vesicles. After a
20-min chase in complete medium without energy poison, FITC-
dextran–containing vesicles moved into the cells (c), and Tf was
mostly returned to the cell surface (d). Bar, 20 mm.
Figure 9. SMase treatment of BODIPY-C12-SM–labeled cells.
TRVb-1 cells were labeled with BODIPY-C12-SM on ice for 30 min.
Cells were incubated with SMase (50 mU/ml) (A) or without (B)
for 5 min. Some of the cells were incubated with SL-O (0.4 U/ml)
for 5 min on ice (C and D), washed with cold PBS and transferred
to 378C for 3 min, and then incubated with SMase (50 mU/ml)/
rhodamine-dextran (5 mg/ml) for 5 min. Cells were washed and
transferred into HF-12 medium for z20 min at room temperature
before being viewed by fluorescence microscopy. Rhodamine-
dextran–containing vesicles (C) colocalized with vesicles labeled
with BODIPY fluorescence (D). Bar, 10 mm.The Journal of Cell Biology, Volume 140, 1998 46
the presence of SMase and could well be decreased after
that because of depletion of sphingomyelin from the plasma
membrane.
Endogenous sphingomyelin is believed to be synthe-
sized in the Golgi and transported to the plasma mem-
brane (Mandon et al., 1992). Ceramide produced by exog-
enous SMase is converted back to sphingomyelin, possibly
in the recycling pathway (Kallen et al., 1994). Both pro-
cesses require ATP. After treating ATP-depleted cells with
SMase, sphingomyelin on the plasma membrane would
eventually be depleted because of either hydrolysis or in-
ternalization. This may explain our observation that up-
take of dextran is a time-limited process. Endocytosis
reaches its maximum within 10 min after exposure to the
enzyme, and further exposure did not generate additional
vesiculation (Fig. 3, closed circles). This suggests that the
formation of the vesicles after 10 min may be limited by
the availability of sphingomyelin on the plasma membrane.
The characterization of endocytosis activated by SMase
has several implications. First, our results demonstrate that
cellular energy is not directly required for the formation of
vesicles that invaginate from the plasma membrane. Since
these vesicles apparently have incorporated nonspecific
membrane, our results imply that much of the plasma
membrane has the information required to recycle recep-
tors and deliver fluid contents to late endosomes. This is
consistent with observations that macropinosomes initially
contain receptors that are removed from them (Racoosin
and Swanson, 1993). The mechanisms for the sorting of
the membrane and fluid contents of the SMase-induced
vesicles are not known. Secondly, our results indicate that
budding and fusion of mammalian cell membranes could
occur as a result of altering the lipid composition of the
membrane. While budding and fusion in living cells are
known to be assisted by proteins such as clathrin and dy-
namin (Schmid, 1992; Hinshaw and Schmid, 1995), there is
increasing evidence that these processes can also be gov-
erned by the properties of the lipids. Several diverse bio-
logical fusion processes, from sea urchin egg cortical exo-
cytosis to mast cell degranulation, have been shown to be
inhibited or enhanced by adding exogenous lipids into the
membrane (Chernomordik et al., 1995). It was reported
that Semliki Forest virus requires sphingomyelin in the
target membrane to fuse (Nieva et al., 1994). It is possible
that mammalian cells may use some lipid-modifying en-
zymes, such as SMase, to change lipid composition locally
and, therefore, promote membrane budding and fusion.
The effect of SMase on cholesterol trafficking must now
be reexamined. It is well known that SMase treatment can
lead to stimulation of cholesterol esterification by trans-
port of free cholesterol from the plasma membrane to in-
tracellular ACAT locations (Slotte and Bierman, 1988).
ACAT is thought to be primarily localized in the endoplas-
mic reticulum, although other intracellular locations have not
been excluded. The mechanism by which cholesterol is
transported from the plasma membrane to ACAT in re-
sponse to SMase treatment is not known at present. It is
known, however, that energy depletion does not impair
this transport (Skiba et al., 1996). How the SMase-induced
vesicles are related to the cholesterol translocation is not
clear. It is possible that these vesicles are enriched with
cholesterol relative to sphingomyelin. This relative enrich-
ment could make cholesterol on these vesicles much more
mobile than cholesterol in conventional endosomes, so
that it can be easily transferred to cholesterol-poor mem-
branes, such as the endoplasmic reticulum. Thus, the vesi-
cles formed by SMase may act as efficient cholesterol trans-
porters.
Although we used a nonphysiological addition of bacte-
rial enzyme to hydrolyze plasma membrane sphingomye-
lin, our results may be relevant to several important bio-
logical processes. Mammalian cells express acidic and
neutral SMases (Das et al., 1984; Merrill and Jones, 1990;
Chatterjee, 1993; Hannun, 1994), and activation of mam-
malian SMases and ceramide production have been impli-
cated in many signal transduction cascades (Hannun,
1994). These regulated SMases were found to be located in
either the cytosol or light membrane fraction, possibly the
plasma membrane (Liu and Anderson, 1995). Further-
more, a Zn-dependent SMase was recently found to be se-
creted by several cell lines (Schissel et al., 1996), and it has
been found that this secreted Zn-dependent SMase is en-
coded by the same gene, mRNA, and protein precursor as
acid lysosomal SMase (Schissel et al., 1996; Schissel, S., E.
Schuchman, K. Williams, and I. Tabas, manuscript submit-
ted for publication). With lipoproteins, treatments such as
oxidation or preexposure to phospholipase A2 cause the
sphingomyelin to become a good substrate for secreted
SMase at pH 7.4 (Callahan et al., 1983; Schissel et al.,
1998). Therefore, even though secreted SMase does not
cause extensive ceramide production when added to mam-
malian cells (our unpublished data), a change in sphingo-
myelin accessibility to the enzyme may occur under some
conditions at the plasma membrane. In summary, there are
various forms of SMase in the extracellular medium and in
the secretory and endocytic compartments of many cells.
Although the mechanisms of activation remain to be
worked out, it is likely that one or more of these forms of
SMase cause significant hydrolysis of sphingomyelin at the
plasma membrane. Our data suggest that among other ef-
fects, activation of SMase would be expected to cause en-
dovesiculation.
Recent data point to a specific example where this oc-
curs (Grassme et al., 1997). Infection by Neisseria gonor-
rhoeae requires entry into mucosal epithelial cells (McGee
et al., 1983). It was found that invasion of human epithelial
cells and primary fibroblasts was accompanied by hydroly-
sis of phosphatidyl choline (PC) by a PC-specific phospho-
lipase C, and by hydrolysis of sphingomyelin by SMase
(Grassme et al., 1997). Approximately 35% of metaboli-
cally labeled sphingomyelin was hydrolyzed within 5 min of
exposure to the bacteria, and the sphingomyelin hydrolysis
did not occur in fibroblasts from Niemann-Pick Disease
type A patients. These fibroblasts lack both the lysosomal
and secreted forms of the (acid) SMase. The Niemann-
Pick A fibroblasts did not internalize Neisseria gonor-
rhoeae in contrast to normal human fibroblasts. Transient
transfection with the SMase gene restored the SMase ac-
tivity after contact with bacteria, and it also restored the
ability to internalize the bacteria in the transfected cells.
Inhibition of PC-specific phospholipase C also reversibly
blocked bacterially induced SMase activity and uptake of
the bacteria. These data suggest that Neisseria gonorrhoeae
can activate a signaling cascade through PC-specific phos-Zha et al. Sphingomyelin-induced Endocytosis 47
pholipase C that activates the target cell’s SMase, resulting
in very extensive and rapid conversion of sphingomyelin
to ceramide. This SMase activity is required for internal-
ization of the bacteria (Grassme et al., 1997).
Our results present an obvious mechanism for the
SMase-dependent uptake of the Neisseria gonorrhoeae
bacteria by the nonphagocytic cells. The massive SMase
activity would drive endovesiculation that could engulf the
bacteria. Further work will be required to determine if the
activation of SMase is localized near the site of bacterial
uptake or if there is a widespread activation.
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